🔎 Trials Near Me

Dachaigh › Leukemia Myeloid ann an Ìre Chronach › Texas › Houston

Sgrùdaidhean clionaigeach Leukemia Myeloid ann an Ìre Chronach ann an Houston, TX

Tha 5 sgrùdaidhean airson Leukemia Myeloid ann an Ìre Chronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT01746836

Study of Olverembatinib (HQP1351) in Patients With CML-CP

A’ fastadhÌre 3
  • Ascentage Investigative Site #1501, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06423911

Personalized NK Cell Therapy in CBT

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05304377

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

A’ fastadhÌre 1/2
  • The University of Texas M.D. Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06163430

Sgrùdaidhean Leukemia Myeloid ann an Ìre Chronach ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.